How GLP-1 and Dual GIP/GLP-1 Agonists Work to Treat Obesity GLP-1 agonists and dual GIP/GLP-1 agonists are medications that increase satiety (the feeling of fullness), slow digestion, and quiet constant thoughts about food (known as food noise), making it easier to lose weight and keep it off
Theres also emerging research suggesting GLP-1 medications may reduce alcohol cravings or intake in some people, although responses can vary quite a bit from person to person
HbA1c reductions, improved insulin sensitivity, and potentially reduced need for diabetes medications can be transformative health outcomes that the scale does not capture
Clinical trials have demonstrated hemoglobin A1c reductions of 1.9% to 2.4% in patients with type 2 diabetes
Potentially fewer PMS symptoms Theres no evidence that Ozempic itself can relieve premenstrual (PMS) symptoms like cramps, bloating, breast tenderness, and mood swings (hello, irritability)
The test reveals predispositions in peptide genetic pathways specifically, not pharmacogenomic drug metabolism